Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
725 Welch Rd
Palo Alto, CA 94304Phone+1 650-497-8000Fax+1 650-722-6350
Summary
- Dr. Brenda Porter is a Child Neurologist in Palo Alto, CA and is affiliated with multiple hospitals in the area, including Lucile Packard Children's Hospital Stanford, Stanford Health Care, and John Muir Medical Center, Walnut Creek. She received her medical degree from Washington University in St. Louis School of Medicine and has been in practice 22 years. She is experienced in tuberous sclerosis, child neurology, and pediatric epilepsy.
Education & Training
- University of Pennsylvania Health SystemResidency, Neurology, 1997 - 2000
- Children's Hospital of PhiladelphiaFellowship, Child Neurology, 1997 - 2000
- Washington University in St. Louis School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 2012 - 2026
- HI State Medical License 2018 - 2026
- NV State Medical License 2020 - 2025
- PA State Medical License 1998 - 2012
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Clinical Neurophysiology
- American Board of Psychiatry and Neurology Epilepsy
Publications & Presentations
PubMed
- Efficacy and safety of perampanel in patients with seizures associated with Lennox-Gastaut syndrome: A randomized trial.David G Vossler, Brenda E Porter, Ryutaro Kira, Jeehun Lee, Alec Aeby
Epilepsia. 2024-11-22 - Sleep Abnormalities in SLC13A5 Citrate Transporter Disorder.Raegan M Adams, Can Ozlu, Lauren E Bailey, Rayann M Solidum, Sydney Cooper
Genes. 2024-10-18 - 1 citationsDrug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.Laura S Farach, Melissa A Richard, Aynara C Wulsin, Elizabeth M Bebin, Darcy A Krueger
Pediatric Neurology. 2024-10-01
Press Mentions
- TESS Research Foundation Selected as Part of Chan Zuckerberg Initiative Rare as One ProjectFebruary 3rd, 2020
- Hadlee’s TSC StoryMay 15th, 2019
- Helping a Child's Brain to HealFebruary 14th, 2019
- Join now to see all
Grant Support
- CRE Mediated Transcription In EpileptogenesisNational Institute Of Neurological Disorders And Stroke2008–2011
- Neurogenesis In Pediatric Temporal Lobe EpilepsyNational Institute Of Neurological Disorders And Stroke2004–2007
- Neurogenesis In Pediatric Temporal Lobe EpilepsyNational Institute Of Neurological Disorders And Stroke2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: